ALKERMES | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
AbbVie USD 610M 19M 2024-12
ALKERMES USD 4.65M 1.35M 2024-12
Amgen USD 747M 29M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
Gilead Sciences USD 248M 10M 2024-12
Intra Cellular Therapies 5.97M 966K 2023-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
J&J USD 137M 56M 2024-12
Merck USD 328M 2M 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Otsuka Holdings 8.89B 8.62B 2024-09
Pfizer USD 739M 45M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



ALKERMES Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.